CATAPRES Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Catapres, and when can generic versions of Catapres launch?
Catapres is a drug marketed by Boehringer Ingelheim and Lavipharm and is included in two NDAs.
The generic ingredient in CATAPRES is clonidine. There are twenty-two drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the clonidine profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Catapres
A generic version of CATAPRES was approved as clonidine by DIFGEN PHARMS on August 18th, 2009.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CATAPRES?
- What are the global sales for CATAPRES?
- What is Average Wholesale Price for CATAPRES?
Summary for CATAPRES
US Patents: | 0 |
Applicants: | 2 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 205 |
Clinical Trials: | 19 |
Patent Applications: | 4,355 |
Drug Prices: | Drug price information for CATAPRES |
Drug Sales Revenues: | Drug sales revenues for CATAPRES |
What excipients (inactive ingredients) are in CATAPRES? | CATAPRES excipients list |
DailyMed Link: | CATAPRES at DailyMed |
Recent Clinical Trials for CATAPRES
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Rigshospitalet, Denmark | Phase 2/Phase 3 |
Deventer Ziekenhuis | Phase 3 |
Queen's University, Belfast | Phase 3 |
US Patents and Regulatory Information for CATAPRES
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Boehringer Ingelheim | CATAPRES | clonidine hydrochloride | TABLET;ORAL | 017407-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Lavipharm | CATAPRES-TTS-1 | clonidine | SYSTEM;TRANSDERMAL | 018891-001 | Oct 10, 1984 | AB | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Boehringer Ingelheim | CATAPRES | clonidine hydrochloride | TABLET;ORAL | 017407-002 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for CATAPRES
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Boehringer Ingelheim | CATAPRES | clonidine hydrochloride | TABLET;ORAL | 017407-001 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
Boehringer Ingelheim | CATAPRES | clonidine hydrochloride | TABLET;ORAL | 017407-003 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
Boehringer Ingelheim | CATAPRES | clonidine hydrochloride | TABLET;ORAL | 017407-002 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for CATAPRES
See the table below for patents covering CATAPRES around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Sweden | 353721 | ⤷ Sign Up | |
Denmark | 108364 | ⤷ Sign Up | |
United Kingdom | 1016514 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |